MedDataX Logo

Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

NCT ID: NCT05833880

Last Updated: 2023-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

89 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-10

Study Completion Date

2023-08-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Complementary and alternative medicine are increasingly used all around the world and more specifically in chronic diseases such as atopic dermatitis. Sociodemographic and disease determinants associated with their use remain unclear. Moreover, most of studies involved children and little data are available for adults.

The main objective of this study is to identify factors associated with complementary and alternative medicine use in children and adults suffering from atopic dermatitis. The secondary objectives are to determine the prevalence of complementary and alternative medicine use, the main forms used and their modalities of use, patients' motivations for using these therapies and sources of information.

Patients of all ages consulting for their atopic dermatitis at the dermatology or pediatric allergology department of Nancy University Hospital over a 6 months period will be asked to fill out a questionnaire about their pathology and their use of complementary and alternative medicine. This questionnaire will be collected before they leave the hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Atopic Dermatitis Atopic Eczema Complementary and Alternative Medicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Atopic dermatitis patients

Self-administered questionnaire

Intervention Type BEHAVIORAL

Self-administered questionnaire regarding complementary and alternative medicine use

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self-administered questionnaire

Self-administered questionnaire regarding complementary and alternative medicine use

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients, adults or children, without age limit;
* Patients visiting the dermatology or pediatric allergology department of Nancy University Hospital;
* Patients with atopic dermatitis confirmed on clinical examination by the physician;
* Patients with a history of atopic dermatitis or newly diagnosed patients;
* Patient affiliated to a social security plan or beneficiary of such a plan;
* Patients who understand French and are able to complete a self-administered questionnaire or have the option of assistance in completing it.

Exclusion Criteria

* Patient with at least one other dermatological pathology or non-atopic eczema (contact eczema, ...);
* Patient without a confirmed diagnosis of atopic dermatitis by a physician;
* Patient who has already completed the questionnaire during a previous consultation;
* Pregnant and breastfeeding women;
* Refusal of the patient or at least one of the parents for children;
* Patient placed under court protection, guardianship or curatorship;
* Patient deprived of liberty by a judicial or administrative decision.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne Claire BURSZTEJN

Director, Head of Dermatology, Principal Investigator, Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne-Claire Bursztejn

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Nancy, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Nancy

Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A00605-40

Identifier Type: -

Identifier Source: org_study_id